• New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

  • Dec 18 2023
  • Length: 22 mins
  • Podcast

New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

  • Summary

  • In every episode of New Insight, Veeral Sheth, MD, Director of Clinical Trials at University Retina in Chicago, takes an in-depth look at the biggest news in ophthalmology and the behind the scenes work involved in eye care, with a rotation of guest experts involved in ophthalmic research, development, and clinical care.

    The latest episode of New Insight features a conversation with Ocuphire Pharma’s CEO on the company’s flagship retinal product and leading a small, but high-powered research team.

    Episode Highlights:
    0:04 Introduction
    1:23 History of Ocuphire Pharma
    3:50 Leading a small, high-functioning team
    6:41 Magrath’s background and journey
    11:02 APX3330 for Diabetic Retinopathy
    15:20 2024 Plans for Ocuphire
    18:53 Addressing unmet needs
    20:20 Outro

    Every episode of New Insight is available on HCPLive.com and be sure to subscribe to our channel on Spotify and Apple Podcasts. Please direct any podcast-related inquiries to show producer Connor Iapoce at ciapoce@mjhlifesciences.com.
    Show more Show less
activate_WEBCRO358_DT_T2

What listeners say about New Insight: A Look at APX3330 for Diabetic Retinopathy with George Magrath, MD

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.